Two new fluvirucin aglycones, named fluvirucinins C1 and C2 (1-2), have been isolated from the ethyl acetate mycelial cake extract of the fermentation broth of a marine sponge-associated actinomycete. Fluvirucinins C1 (1) and C2 (2) represent a new type of 14-membered macrolactam aglycon, structurally related with the common aglycon of the known fluvirucins. Their structures were elucidated on the basis of 1D and 2D NMR analyses, as well as HRESIMS experiments. The antimicrobial and cytotoxic activities of compounds 1 and 2 have been evaluated, but no significant activities found for fluvirucinins C1 and C2.
NaruseN, TsunoT, SawadaY, KonishiM, OkiT. (1991) Fluvirucins A1, A2, B1, B2, B3, B4 and B5, new antibiotics active against influenza A virus II. Structure determination. Journal of Antibiotics, 44, 741–755.
2.
HegdeVR, PatelMG, GulloVP, HoranAC, KingAH, GentileF, WagmanGH, PuarMS, LoebenbergD. (1993) A novel macrolactam-disaccharide antifungal antibiotic. Taxonomy, fermentation, isolation, physico-chemical properties, structure elucidation and biological activity. Journal of Antibiotics, 46, 1109–1115.
3.
HegdeVR, PatelMG, HoranAC, KingAH, GentileF, PuarMS, LoebenbergD. (1998) A novel macrolactam-trisaccharide antifungal antibiotic. Taxonomy, fermentation, isolation, physico-chemical properties, structure elucidation and biological activity. Journal of Antibiotics, 51, 464–470.
4.
HegdeVR, PatelMG, GulloVP, GangulyAK, SarreO, PuarMS, McPhailAT. (1990) Macrolactams: a new class of antifungal agents. Journal of the American Chemical Society, 112, 6403–6405.
5.
CooperR, TruumeesI, YarboroughR, LoebenbergD, MarquezJ, HoranA, PatelM, GulloV, PuarM, PramanikB. (1992) Macrolactams: two novel homologous series of compounds produced by Actinomadura sp. SCC 1778. Journal of Antibiotics, 45, 633–638.
6.
HegdeV, PatelM, HoranA, GulloV, MarquezJ, GunnarssonI, GentileF, LoebenbergD, KingA, PuarM., PramanikB. (1992) Macrolactams: a novel class of antifungal antibiotics produced by Actinomadura spp. SCC 1776 and SCC 1777. Journal of Antibiotics, 45, 624–632.
7.
HegdeVR, PatelMG, GulloVP, PuarS. (1991) Sch 38518 and Sch 39185: two novel macrolactam antifungals. Journal of the Chemical Society, Chemical Communications, 12, 810–812.
LlàcerE, UrpíF, VilarrasaJ. (2009) Efficient approach to Fluvirucins B2-B5, Sch 38518, and Sch 39185. First synthesis of their aglycon, via CM and RCM reactions. Organic Letters, 11, 3198–3201.
11.
XuZ, JohannesCW, HouriAF, LaDS, CoganDA, HofilenaGE, HoveydaAH. (1997) Applications of Zr-catalyzed carbomagnesation and Mo-catalyzed macrocyclic ring closing metathesis in asymmetric synthesis. Enantioselective total synthesis of Sch 38516 (Fluvirucin B1). Journal of the American Chemical Society, 119, 10302–10316.
12.
XuZ, JohannesCW, SalmanSS, HoveydaAH. (1996) Enantioselective total synthesis of antifungal agent Sch 38516. Journal of the American Chemical Society, 118, 10926–10927.
13.
AmatM, LlorN, GuignardG, BoschJ. (2016) Synthesis of fluvirucins and their aglycons, the fluvirucinins. Synthesis, 48, 2705–2720.
14.
LinT-Y, BorketeyLS, PrasadG, WatersSA, SchnarrNA. (2013) Sequence, cloning, and analysis of the fluvirucin B1 polyketide synthase from Actinomadura vulgaris. ACS Synthetic Biology, 2, 635–642.
15.
MiyanagaA, HayakawaY, NumakuraM, HashimotoJ, TeruyaK, HiranoT, Shin-yaK, KudoF, EguchiT. (2016) Identification of the fluvirucin B2 (Sch 38518) biosynthetic gene cluster from Actinomadura fulva subsp. indica ATCC 53714: substrate specificity of the β-amino acid selective adenylating enzyme FlvN. Bioscience, Biotechnology, and Biochemistry, 80, 935–941.
16.
SubramaniR, AalbersbergW. (2012) Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiological Research, 167, 571–580.
17.
ZotchevSB. (2012) Marine actinomycetes as an emerging resource for the drug development pipelines. Journal of Biotechnology, 158, 168–175.
18.
MontalvoNF, MohamedNM, EnticknapJJ, HillRT. (2005) Novel actinobacteria from marine sponges. Antonie van Leeuwenhoek, 87, 29–36.
Fernandez-ChimenoRI, CanedoL, EspliegoF, GravalosD, De La CalleF, Fernandez-PuentesJL, RomeroF. (2000) IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation and biological activities. Journal of Antibiotics, 53, 474–478.
21.
LiuR, CuiC-B, DuanL, GuQ-Q, ZhuW-M. (2005) Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov. Archives of Pharmacal Research, 28, 1341–1344.
22.
NaruseN, KonishiM, OkiT, YoshinobuI, KakisawaH. (1991) Fluvirucins A1, A2,A1, A2, A3, A4 and A5, new antibiotics active against influenza a virus III. The stereochemistry and absolute configuration of fluvirucin A1. Journal of Antibiotics, 44, 756–761.
23.
BonevB, HooperJ, ParisotJ. (2008) Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method. Journal of Antimicrobial Chemotherapy, 61, 1295–1301.
24.
SkehanP, StorengR, ScudieroD, MonksA, McMahonJ, VisticaD, WarrenJT, BokeschH, KenneyS, BoydMR. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute, 82, 1107–1112.
25.
ShoemakerRH. (2006) The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer, 6, 813–823.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
